Table 1.

Human prostate samples and corresponding clinical data

Sample ID	Diagnosis	Gleason grade	Gleason score (highest)	Stage	Treatment	Age	Race	Ethnicity	PSA at sample acquisition
LHu1	Adenocarcinoma	GG3	4 + 3 and 3 + 3	pT2N0	None	51–60: 20% 61–70: 80%	White: 40% Combination not described: 60%	Non-Hispanic: 60% Hispanic: 40%	PSA < 4: 0 patients PSA < 10: 2 patients PSA > 10: 3 patients
LHu2	Adenocarcinoma	GG1	3 + 3	pT2N0	None
LHu3	Adenocarcinoma (metastatic)	GG5	4 + 5	ypT3N1	Degarelix
LHu4	Adenocarcinoma	GG2	3 + 4	pT3N0	None
LHu5	Adenocarcinoma	GG4	4 + 4	pT2N0	Tamsulosin